Abstract
The purpose of this study was to assess if there exists an association between C34T muscle adenosine monophosphate deaminase (AMPD1 ) genotypes (i.e., normal homyzygotes [CC ] vs. heterozygotes [CT ]) and directly measured indices of exercise capacity (peak oxygen uptake [V·O2peak ], ventilatory threshold [VT], gross mechanical efficiency [GE], etc.) in 44 Caucasian McArdle patients (23 males, 21 females). All patients performed a graded cycle ergometer test until exhaustion (for V·O2peak and VT determination) and a 12-min constant-load test at the power output eliciting the VT (for GE determination). We found no significant difference in indices of exercise capacity between CC (n = 18) and CT genotypes (n = 5) in the group of male patients (p > 0.05). In contrast, the V·O2 at the VT was significantly lower (p < 0.05) in CT (n = 4; 7.9 ± 0.4 ml/kg/min) than in CC female patients (n = 17; 11.0 ± 0.9 ml/kg/min). In summary, heterozigosity for the C34T allele of the AMPD gene is associated with reduced submaximal aerobic capacity in female patients with McArdle disease and might partly account, in this gender, for the variability that exists in the phenotypic manifestation of the disease.
Key words
glycogenosis type V - AMP deaminase - ventilatory threshold - V·O2peak
References
1
Bruno C, Cassandrini D, Martinuzzi A, Toscano A, Moggio M, Morandi L, Servidei S, Mongini T, Angelini C, Musumeci O, Comi G P, Lamperti C, Filosto M, Zara F, Minetti C.
McArdle disease: the mutation spectrum of PYGM in a large Italian cohort.
Hum Mutat.
2006;
27
718
2
Burki N K, Alam M, Lee L-Y.
The pulmonary effects of intravenous adenosine in asthmatic subjects.
Respir Res.
2006;
30 (7)
139
3
Burki N K, Dale W J, Lee L-Y.
Intravenous adenosine and dyspnea in man.
J Appl Physiol.
2005;
98
180-185
4
Chavarren J, Calbet J AL.
Cycling efficiency and pedalling frequency in road cyclists.
Eur J Appl Physiol.
1999;
80
555-563
5
Coleridge J C, Coleridge H M.
Afferent vagal C fibre innervation of the lungs and airways and its functional significance.
Rev Physiol Biochem Pharmacol.
1984;
99
1-110
6
Engelstein E D, Lerman B B, Somers V K, Rea R F.
Role of arterial chemoreceptors in mediating the effects of endogenous adenosine on sympathetic nerve activity.
Circulation.
1994;
90
2919-2926
7
Gitt A K, Wasserman K, Kilkowski C, Kleemann T, Kilkowski A, Bangert M, Schneider S, Schwarz A, Senges J.
Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death.
Circulation.
2002;
10
3079-3084
8
Griffiths T L, Warren S J, Chant A D, Holgate S T.
Ventilatory effects of hypoxia and adenosine infusion in patients after bilateral carotid endarterectomy.
Clin Sci.
1990;
78
25-31
9
Gross M, Rotzer E, Kolle P, Mortier W, Reichmann H, Goebel H H, Lochmuller H, Pongratz D, Mahnke-Zizelman D K, Sabina R L.
G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population.
Neuromuscul Disord.
2002;
12
558-565
10
Hagberg J M, Coyle E F, Carroll J E, Miller J M, Martin W H, Brooke M H.
Exercise hyperventilation in patients with McArdle's disease.
J Appl Physiol.
1982;
52
991-994
11
Hagberg J M, King D S, Rogers M A, Mountain S J, Jilka S M, Kohrt W M, Heller S L.
Exercise and recovery ventilatory and V·O2 responses of patients with McArdle's disease.
J Appl Physiol.
1990;
68
1393-1398
12
Heller S L, Kaiser K K, Planer G L, Hagberg J M, Brooke M H.
McArdle's disease with myoadenylate deaminase deficiency: observations in a combined enzyme deficiency.
Neurology.
1987;
37
1039-1042
13
Koike A M, Hiroe M, Adachi H, Yajima T, Nogami A, Ito H, Takamoto T, Taniguchi K, Marumo F.
Anaerobic metabolism as an indicator of aerobic function during exercise in cardiac patients.
J Am Coll Cardiol.
1992;
20
120-126
14
Lowenstein J M.
Ammonia production in muscle and other tissues: the purine nucleotide cycle.
Physiol Rev.
1972;
52
382-414
15
Lucia A, Hoyos J, Santalla A, Earnest C, Chicharro J L.
Tour de France vs. Vuelta a España: which is harder?.
Med Sci Sports Exerc.
2003;
35
872-878
16
Lucia A, Maté-Muñoz J L, Pérez M, Gutierrez-Rivas E, Foster C, Arenas J.
Double trouble (McArdle's disease and myasthenia gravis): how can exercise help?.
Muscle Nerve.
2007;
35
125-128
17
Martin M A, Rubio J C, Buchbinder J, Fernandez-Hojas R, del Hoyo P, Teijeira S, Gámez J, Navarro C, Fernández J M, Cabello A, Campos Y, Cervera C, Culebras J M, Andreu A L, Fletterick R, Arenas J.
Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study.
Ann Neurol.
2001;
50
574-581
18
Martinuzzi A, Sartori E, Fanin M, Nascimbeni A, Valente L, Angelini C, Siciliano G, Mongini T, Tonin P, Tomelleri G, Toscano A, Merlini L, Bindoff L A, Bertelli S.
Phenotype modulators in myophosphorylase deficiency.
Ann Neurol.
2003;
53
497-502
19
Matsumura N, Nishijima H, Kojima S, Hashimoto F, Minami M, Yasuda H.
Determination of anaerobic threshold for assessment of functional state in patients with chronic heart failure.
Circulation.
1983;
68
360-367
20
Maxwell D L, Fuller R W, Nolop K B, Dixon C M, Hughes J M.
Effects of adenosine on ventilatory responses to hypoxia and hypercapnia in humans.
J Appl Physiol.
1986;
61
1762-1766
21
McArdle B.
Myophaty due to a defect in muscle glycogen breakdown.
Clin Sci.
1951;
10
13-33
22
Meyer T, Lucia A, Earnest C P, Kindermann W.
A conceptual framework for performance diagnosis and training prescription from submaximal gas exchange parameters - theory and application.
Int J Sports Med.
2005;
26 (Suppl 1)
S38-S48
23
Morisaki T, Gross M, Morisaki H, Pongratz D, Zollner N, Holmes E W.
Molecular basis of AMP deaminase deficiency in skeletal muscle.
Proc Natl Acad Sci USA.
1992;
89
6457-6661
24
Norman B, Glenmark B, Jansson E.
Muscle AMP deaminase deficiency in 2 % of healthy population.
Muscle Nerve.
1995;
18
239-241
25
Norman B, Sabina R L, Jansson E.
Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjects.
J Appl Physiol.
2001;
91
258-264
26
Pérez M, Martin M A, Cañete S, Rubio J C, Fernández-Moreira D, San Juan A F, Gómez-Gallego F, Santiago C, Arenas J, Lucia A.
Does the C34T mutation in AMPD1 alter exercise capacity in the elderly?.
Int J Sports Med.
2006;
27
429-435
27
Pérez M, Martin M A, Rubio J C, Maté-Muñoz J L, Gómez-Gallego F, Foster C, Andreu A L, Arenas J, Lucia A.
Exercise capacity in a 78 year old patient with McArdle's disease: it is never too late to start exercising.
Br J Sports Med.
2006;
40
725-726
28
Rico-Sanz J, Rankinen T, Joanisse D R, Leon A S, Skinner J S, Wilmore J H, Rao D C, Bouchard C.
Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE family study.
Physiol Genomics.
2003;
14
161-166
29
Riley M, Nicholls D P, Nugent A-M, Steele I C, Bell N, Davies P M, Stanford C F, Patterson V H.
Respiratory gas exchange and metabolic responses during exercise in McArdle's disease.
J Appl Physiol.
1993;
75
745-754
30
Rubio J C, Martin M A, Del hoyo P, Bautista J, Campos Y, Segura D, Navarro C, Ricoy J R, Cabello A, Arenas J.
Molecular analysis of Spanish patients with AMP deaminase deficiency.
Muscle Nerve.
2000;
23
1175-1178
31
Rubio J C, Nogales-Gadea G, Garcia-Consuegra I, Blázquez A, Cabello A, Lucia A, Andreu A L, Arenas J, Martin M A.
A proposed molecular diagnosis flowchart for myophopshorylase deficiency (McArdle disease) in blood samples from Spanish patients.
Hum Mutat.
2007;
28
203-204
32
Tarnopolsky M A, Parise G, Gibala M J, Graham T E, Rush J W.
Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans.
J Physiol.
2001;
533
881-889
33
Tsujino S, Shanske S, Dimauro S.
Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle disease).
N Engl J Med.
1993;
329
241-245
34
Vissing J, Haller R G.
The effect of oral sucrose on exercise tolerance in patients with McArdle's disease.
N Engl J Med.
2003;
349
2503-2509
35
Winder W W.
Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle.
J Appl Physiol.
2001;
91
1017-1028
Prof. Alejandro Lucia
Physiology Universidad Europea de Madrid
Villaviciosa de Odón
28670 Madrid
Spain
Phone: + 34 9 16 64 78 00
Fax: + 34 9 16 16 82 65
Email: alejandro.lucia@uem.es